On the other hand, Lp(a) and Lp‐PLA2 can participate in the occurrence of cardiovascular and cerebrovascular diseases by modulating oxidized phospholipids (OxPLs) [6, 7, 8]. This evidence concerns the gene PLA2G7 and cerebrovascular disorder.